Prenetics Global Limited, a leading health sciences company, today announced that Tencent has made a strategic US$30 million investment in Insighta, a Hong Kong-based early cancer detection company. This investment values Insighta at US$200 million and underscores Tencent’s endeavor to advancing AI-powered innovations in healthcare..

领先的健康科学公司Prenetics Global Limited今天宣布，腾讯已向总部位于香港的早期癌症检测公司Insighta投资3000万美元。这项投资对Insighta的估值为2亿美元，突显了腾讯努力推进人工智能推动的医疗创新。。

Following the transaction, Prenetics’ stake in Insighta will be reduced from 50% to 35%. Insighta’s co-founders will retain their 50% shareholding. As part of the agreement, Prenetics has received US$30 million in cash from the sale of secondary shares to Tencent, boosting its pro forma cash and other current short-term assets1 to over US$90 million at closing of the transaction.

交易完成后，Prenetics在Insighta的持股比例将从50%降至35%。Insighta的联合创始人将保留其50%的股权。作为协议的一部分，Prenetics从向腾讯出售二级股中获得了3000万美元的现金，在交易结束时，其形式现金和其他当前短期资产1增至9000多万美元。

Tencent will also gain a seat on Insighta’s Board of Directors, to be held by Alexander Ng, President of Tencent Healthcare..

腾讯还将获得Insighta董事会的席位，由腾讯医疗总裁Alexander Ng担任。。

Insighta’s early cancer detection platform is powered by its proprietary FRAGMA technology, a cutting-edge system designed to detect DNA methylation aberrations in cell-free DNA (cfDNA) in bodily fluids such as blood. By identifying specific fragment patterns associated with cancer cells, FRAGMA enables non-invasive, highly accurate early epigenetics-based detection of multiple cancers.

Insighta的早期癌症检测平台由其专有的FRAGMA技术提供支持，该技术是一种尖端系统，旨在检测血液等体液中无细胞DNA（cfDNA）中的DNA甲基化畸变。通过鉴定与癌细胞相关的特定片段模式，FRAGMA能够对多种癌症进行非侵入性，高度准确的基于早期表观遗传学的检测。

Epigenetics is the study of biochemical modifications of the genome without changes in DNA sequences. This ingenious approach in detecting fragmented DNA signatures allows the cost-effective detection of cancer, making FRAGMA a crucial innovation in cancer detection..

表观遗传学是在不改变DNA序列的情况下对基因组进行生化修饰的研究。这种检测片段化DNA特征的巧妙方法可以经济高效地检测癌症，使FRAGMA成为癌症检测的关键创新。。

Insighta has commenced clinical trials in Mainland China, focusing initially on liver cancer, and will soon expand to include lung cancer detection. Insighta is also actively developing tests for additional cancer types, and plans on updating as appropriate.

Insighta已在中国大陆开始临床试验，最初专注于肝癌，并将很快扩展到肺癌检测。Insighta还积极开发针对其他癌症类型的测试，并计划酌情更新。

With US$80 million in cash reserves, Insighta is well-capitalized to fund these trials and expedite the commercialization of its revolutionary cancer detection technology in the next few years.

Insighta拥有8000万美元的现金储备，资金充足，可以为这些试验提供资金，并在未来几年加速其革命性癌症检测技术的商业化。

“We are excited to welcome Tencent as a strategic investor,” said Professor Allen Chan, co-founder of Insighta. “Their expertise in AI, combined with our proprietary FRAGMA technology, positions us to make significant strides in improving early cancer diagnosis, which can greatly enhance patient outcomes worldwide.”.

Insighta联合创始人艾伦·陈教授表示：“我们很高兴欢迎腾讯成为战略投资者。”。“他们在人工智能方面的专业知识，加上我们专有的FRAGMA技术，使我们能够在改善早期癌症诊断方面取得重大进展，这可以大大提高全球患者的预后。”。

Tencent’s robust AI resources and healthcare expertise are expected to propel Insighta’s technological advancements even further. This is conducive to facilitating the widespread application of FRAGMA technology in early screening for multiple types of cancer, thereby improving prevention strategies for cancer..

腾讯强大的人工智能资源和医疗保健专业知识有望进一步推动Insighta的技术进步。这有助于促进FRAGMA技术在多种癌症早期筛查中的广泛应用，从而改进癌症的预防策略。。

“Tencent sees tremendous potential in Insighta’s FRAGMA-powered approach to early cancer detection,” said Alexander Ng, President of Tencent Healthcare. “We look forward to deepening our partnership with Insighta through various dimensions, including technical collaboration and financial investment.

腾讯医疗总裁Alexander Ng表示：“腾讯认为Insighta基于FRAGMA的早期癌症检测方法具有巨大潜力。”。“我们期待着通过各种层面加深与Insighta的合作关系，包括技术合作和金融投资。

In the future, leveraging Tencent’s leading AI technology and service platform, we will strive to improve the accuracy of early cancer detection using FRAGMA technology, reduce service costs, and further enhance accessibility. Together, we believe we can make significant progress in improving the accuracy of early cancer diagnosis and ultimately save lives.”.

未来，利用腾讯领先的人工智能技术和服务平台，我们将努力提高使用FRAGMA技术进行早期癌症检测的准确性，降低服务成本，并进一步增强可访问性。总之，我们相信我们可以在提高早期癌症诊断的准确性并最终挽救生命方面取得重大进展。”。

Danny Yeung, CEO of Prenetics, commented on the transaction: “This investment marks another significant step for Insighta as it continues its mission to transform cancer detection. With Tencent now on board, Insighta is well-positioned to accelerate clinical development and commercialization efforts.

Prenetics首席执行官丹尼·杨（Danny Yeung）对这笔交易发表了评论：“这项投资标志着Insighta迈出了重要的一步，因为Insighta继续致力于改变癌症检测。随着腾讯的加入，Insighta已经做好了加速临床开发和商业化努力的准备。

Prenetics remains committed to Insighta’s long-term success and will continue to support its groundbreaking work.”.

Prenetics仍然致力于Insighta的长期成功，并将继续支持其开创性的工作。”。

ABOUT PRENETICS

关于PRENETICS

Prenetics (NASDAQ:PRE), a leading health sciences company, is dedicated to advancing consumer and clinical health. Our consumer initiative is led by IM8, a new health and wellness brand and Europa, the largest sports distribution company in the USA. Our clinical division is led by Insighta, our $200 million joint venture focused on multi-cancer early detection technologies.

Prenetics（纳斯达克股票代码：PRE）是一家领先的健康科学公司，致力于促进消费者和临床健康。我们的消费者计划由新的健康和保健品牌IM8和美国最大的体育分销公司Europa领导。我们的临床部门由Insighta领导，Insighta是我们2亿美元的合资企业，专注于多种癌症早期检测技术。

This is followed by ACT Genomics, which has achieved FDA clearance for comprehensive genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer comprehensive DNA tests. Each of Prenetics’ units synergistically enhances our global impact on health, embodying our commitment to ‘enhancing life through science’. .

其次是ACT Genomics，它已经获得FDA对实体瘤全面基因组分析的批准，以及CircleDNA，它使用NGS提供全面的DNA测试。Prenetics的每个单位都协同增强了我们对健康的全球影响，体现了我们对“通过科学增强生命”的承诺。。。

To learn more about Prenetics, please visit prenetics.com.

要了解有关Prenetics的更多信息，请访问Prenetics.com。

ABOUT TENCENT

关于腾讯

Tencent uses technology to enrich the lives of Internet users. Its communication and social services, Weixin and QQ, connect users with each other and with digital content and services, both online and offline, making their lives more convenient. Its targeted advertising service helps advertisers reach out to hundreds of millions of consumers in China.

腾讯利用科技来丰富网民的生活。它的通信和社交服务，微信和QQ，将用户彼此联系起来，并通过在线和离线的数字内容和服务，使他们的生活更加方便。其有针对性的广告服务帮助广告商接触到中国数亿消费者。

Its FinTech and business services support our partners’ business growth and assist their digital upgrade. Tencent invests heavily in talent and technological innovation, actively promoting the development of the Internet industry. Tencent was founded in Shenzhen, China, in 1998. Tencent has been listed on the Main Board of the Stock Exchange of Hong Kong since 2004..

。腾讯大力投入人才和技术创新，积极推动互联网产业发展。腾讯于1998年在中国深圳成立。腾讯自2004年起在香港联合交易所主板上市。。

Investor Relations Contact:

投资者关系联系人：

Shannon Devine

香农·迪瓦恩

MZ North America

MZ北美

[email protected]

[受电子邮件保护]

(203) 741-8811

(203) 741-8811

Angela Cheung

张安琪（AngelaCheung）

Investor Relations / Corporate Finance

投资者关系/公司财务

Prenetics Global Limited

Prenetics Global Limited公司

[email protected]

[受电子邮件保护]

1. Represents current assets, including cash and cash equivalents, financial assets at fair value through profit or loss, and trade receivables, amongst other accounting line items under current assets based on unaudited management account prior to the closing of the transaction.

表示流动资产，包括现金和现金等价物、以公允价值计量且其变动计入当期损益的金融资产和贸易应收款，以及交易结束前基于未经审计管理账户的流动资产下的其他会计项目。